Newsletter | April 25, 2025

04.25.25 -- Amgen's Ian Thompson On Leadership And A Global Mindset

FROM THE EDITOR

Amgen's Ian Thompson On Leadership And A Global Mindset

Ian Thompson, SVP and general manager of U.S. business operations at Amgen, shares his leadership philosophy, what he's learned from working in global markets, and key pipeline highlights.

INDUSTRY INSIGHTS

Are Drugs Becoming More Lipophilic Over Time?

Get a deeper look into how drug lipophilicity has evolved over time, its impact on drug development, and the need for new technology to enable new more complex drugs.

The Future Of Clinical Research Enrollment

To address challenges such as limited patient awareness, mistrust, and logistical barriers, the industry must embrace technology-driven solutions and community-centered outreach.

The Power Of Patient Preferences: Technology And Payment Automation

How can you leverage customizable, simplified payment methods and third-party providers to improve patient convenience in your clinical trial?

Key Analytical Considerations For Developing A Clinical AAV Program

Unlike traditional drugs, AAV therapies require extensive characterization and testing, demanding varying degrees of analysis at each stage of development.

Leveraging Internal And External Insights For Precision Enrollment Modeling

Discover how TA Scan’s innovative Trial Feasibility Flex tool empowers teams to integrate their own insights, driving more accurate and informed projections.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.